CMO Tal Zaks bids Mod­er­na a sur­prise adieu as biotech projects $18.4B in rev­enue, plots post-Covid ex­pan­sion

How do you ex­it a com­pa­ny af­ter six years in style? De­vel­op­ing one of the most lu­cra­tive and life-sav­ing prod­ucts in phar­ma his­to­ry is prob­a­bly not the worst way to go.

Tal Zaks, Mod­er­na’s CMO since 2015, will leave the mR­NA biotech in Sep­tem­ber, the biotech dis­closed in their an­nu­al re­port this morn­ing. The com­pa­ny has al­ready re­tained the re­cruit­ment firm Rus­sell Reynolds to find a re­place­ment.

“Tal joined us when we were a pre-clin­i­cal com­pa­ny. His guid­ance and con­tri­bu­tions were im­por­tant in help­ing Mod­er­na get to where we are to­day,” CEO Stéphane Ban­cel said in a state­ment. “Through his lead­er­ship over the past year in Mod­er­na’s re­sponse to the COVID-19 pan­dem­ic, Tal has made a con­tri­bu­tion that ex­tends be­yond Mod­er­na to all of so­ci­ety. I have en­joyed hav­ing him as my part­ner and wish him all the best as he em­barks on the next leg of his ca­reer.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER